PDB11 LONG-TERM COST-EFFECTIVENESS ANALYSIS OF REPAGLINIDE VERSUS NATEGLINIDE IN COMBINATION WITH METFORMIN IN TYPE 2 DIABETES PATIENTS FAILING MONOTHERAPY IN THE SWEDISH SETTING
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63281-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63281-0/fulltext
Title :
PDB11 LONG-TERM COST-EFFECTIVENESS ANALYSIS OF REPAGLINIDE VERSUS NATEGLINIDE IN COMBINATION WITH METFORMIN IN TYPE 2 DIABETES PATIENTS FAILING MONOTHERAPY IN THE SWEDISH SETTING
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63281-0&doi=10.1016/S1098-3015(10)63281-0
First page :
Section Title :
Open access? :
No
Section Order :
132